Phillip A. Sharp - May 22, 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Director
Signature: /s/ Sung Lee, Attorney-in-Fact
Stock symbol: VIR
Transactions as of: May 22, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/24/2023, 02:35 PM
Previous filing: May 19, 2023
Next filing: Mar 1, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Award	$0	+6.03K	+5.23%	$0.00	121K	May 22, 2023	Direct
holding	VIR	Common Stock						44.4K	May 22, 2023	See footnote	F1
holding	VIR	Common Stock						44.4K	May 22, 2023	See footnote	F2
holding	VIR	Common Stock						44.4K	May 22, 2023	See footnote	F3

Showing 1 to 4 of 4 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Award	$0	+12.1K		$0.00	12.1K	May 22, 2023	Common Stock	12.1K	$25.74	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Sarah Brokaw, over which the reporting person's spouse is co-trustee.
F2	The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Helena Sharp, over which the reporting person's spouse is co-trustee.
F3	The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Christine Carey, over which the reporting person's spouse is co-trustee.